Vibegron (Gemtesa) – a new drug for overactive bladder

Vibegron (brand name: Gemtesa) is the latest drug used to treat overactive bladder that has been approved by the FDA in the USA. Gemtesa will be available in the US as prescription-only medication from April 2021. In this post, I will summarise:  

  • Licensed use and legal status of vibegron (US)
  • It’s a mechanism of action 
  • The effectiveness of vibegron: summary of clinical trial 
  • vibegron vs mirabegron: what is the difference?
  • Alternative drugs used in the treatment of overactive bladder in the UK 

Continue reading “Vibegron (Gemtesa) – a new drug for overactive bladder”